iVIEW Therapeutics
Doylestown
About iVIEW Therapeutics
IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis. The company was founded in 2015 by Bo Liang and John Baldwin and is based in Doylestown, Pennsylvania, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $64.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: iviewtherapeutics.com
- Phone: 267-370-5223
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/iview-therapeutics-15657 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.